4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-23-014843
EVP, CFO & Treasurer sold 11,205 shares at $3.03 ($33,942)
- EVP, CFO & Treasurer acquired 95,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Mason Michael · EVP, CFO & Treasurer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-02-28 | Grant or award : show line 1 in the form | +95,000 | 256,566 | D | ||
| 2023-03-01 | Sale : show line 2 in the form | −11,205 | $3.03 | $33,942 | 245,361 | D |
| Open-market sales · 11,205 sh · avg $3.03 · $33,942 | ||||||
Loading xslF345X03/doc4.xml…